Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Exagen Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 31 | 33 | +2 |
| Shares | 6.20M | 6.29M | +80.8K (+1.3%) |
| Value | $9.87M | $11.4M | +$1.57M (+16.0%) |
New holders (2)
Institutions that held Exagen Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 76,513 | $139.3K | 0.00% |
| Simplex Trading, LLC | 634 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Exagen Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
None.